Production (Stage)
Moleculin Biotech, Inc.
MBRX
$0.67
-$0.0201-2.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.23M | -21.76M | -30.15M | -25.17M | -26.82M |
| Total Depreciation and Amortization | 125.00K | 126.00K | 130.00K | 129.00K | 129.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -467.00K | -2.46M | 3.95M | 519.00K | 2.23M |
| Change in Net Operating Assets | 1.86M | 231.00K | 2.40M | -595.00K | 171.00K |
| Cash from Operations | -21.71M | -23.86M | -23.68M | -25.11M | -24.29M |
| Capital Expenditure | -13.00K | -13.00K | -94.00K | -122.00K | -124.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.00K | -13.00K | -94.00K | -122.00K | -124.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.66M | 4.66M | 8.62M | 3.96M | 4.03M |
| Repurchase of Common Stock | -26.00K | -26.00K | -26.00K | -29.00K | -25.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.63M | 4.64M | 8.59M | 3.93M | 4.00M |
| Foreign Exchange rate Adjustments | -20.00K | -32.00K | 7.00K | -17.00K | -26.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.11M | -19.27M | -15.17M | -21.33M | -20.44M |